<DOC>
	<DOCNO>NCT00342797</DOCNO>
	<brief_summary>A series 1,729 retinoblastoma ( RB ) patient identify medical record hospital center Boston ( 1937-84 ) New York ( 1914-84 ) . The study cohort consist 1,604 patient survive least 1 year RB diagnosis . Information obtain medical record interview conduct 1987 1993 . RB patient 30-fold excess risk another cancer , 50 % chance develop cancer survive 50 year age . Blood sample collect 481 patient , study underway determine certain mutation RB1 gene associate increase decreased penetrance increase risk subsequent cancer development . The study population New York expand currently include patient treat since 1984 , medical record abstract . Blood sample collect newly identify patient return New York Hospital followup RB exam .</brief_summary>
	<brief_title>Retinoblastoma Biomarker Study</brief_title>
	<detailed_description>A series 1,729 retinoblastoma ( RB ) patient identify medical record hospital center Boston ( 1937-84 ) New York ( 1914-84 ) . The study cohort consist 1,604 patient survive least 1 year RB diagnosis . Information obtain medical record interview conduct 1987 1993 . RB patient 30-fold excess risk another cancer , 50 % chance develop cancer survive 50 year age . Blood sample collect 481 patient , study underway determine certain mutation RB1 gene associate increase decreased penetrance increase risk subsequent cancer development . The study population New York expand currently include patient treat since 1984 , medical record abstract . Blood sample collect newly identify patient return New York Hospital followup RB exam .</detailed_description>
	<mesh_term>Retinoblastoma</mesh_term>
	<criteria>INCLUSION CRITERIA : Children treat retroblastoma past 30plus year .</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 29, 2016</verification_date>
	<keyword>second primary cancer</keyword>
	<keyword>retinoblastoma</keyword>
	<keyword>RB1 germline mutation</keyword>
</DOC>